BY OUR PLATFORMS
BY THERAPEUTIC AREA
BY RESEARCH STAGE
Cooperation and networking is key for the success of the modern research effort. For this reason ZeClinics works with leading companies and organizations to develop science and build an international network together.
The PRBB, one of the largest scientific infrastructures in Europe dedicated to biomedical research, offers the highest technological and networking platform to ensure the best quality of ZeClinics services.
The University Pompeu Fabra Business Shuttle department guarantees the positioning of ZeClinics in the fascinating and dynamic business of the Catalan Bio Region.
The Germans Trias i Pujol Research Institute is a public research centre in the Autonomous region of Catalonia in Northern Spain dedicated to increasing scientific knowledge and transferring it to improve the care and lives of patients.
The Department of Experimental and Health Sciences (DCEXS) was founded by Universitat Pompeu Fabra (UPF) and gives full support to the ZeClinics project.
Bellvitge Biomedical Research Institute (IDIBELL) is a research centre focused on cellular medicine, where the high-level basic research focuses and works on relevant clinical matters and fosters economic development.
Cobo Scientific is a Biomedical company with focus on innovative and unique products and services within the BioMedical Research and Drug Discovery segments.
Taros’ drug discovery division is committed to accelerating potential new medicines into clinical development, adding considerable value to drug discovery collaborations by boosting collaborators’ discovery programs from target validation and hit identification to lead generation and optimization.
ZeClinics has received funding from the Ministry of Science and Innovation – State Research Agency through the following programs: EMPLEA, Doctorados Industriales, Torres Quevedo and Retos Colaboración 2019 (NanoDIRE-CT, ref. RTC2019-006809-1, funding 583,178.84€).
INA Research Inc., is a Japanese company based in Tokyo with a team of professionals well versed in nonclinical and clinical trials of pharmaceutical products development.
The Vall d’Hebron Research Institute (VHIR) promotes and develops bio-sanitary research and innovation on the Vall d’Hebron Hospital Campus.
The National Center for Cardiovascular Research (CNIC) is a Spanish body dependent on the Ministry of Science and Innovation and the Carlos III Health Institute.
The Higher Council for Scientific Research (CSIC) is a Spanish state agency attached to the Ministry of Science and Innovation. Its fundamental objective is to develop and promote research for the benefit of scientific and technological progress.
The University of Bern offers excellence in teaching and research across the board as a comprehensive institution.
Inoviem Scientific is a privately-owned Contract Research Biotech offering preclinical and clinical services that use cutting-edge proprietary technologies to speed up drug development.
The German Center for Neurodegenerative Diseases (DZNE) is an interdisciplinary research institution that investigates neurodegenerative disease in all its facets.
ZeClinics has received financial support from ACCIO – Catalan Agency for Business Competitiveness under “Nuclis Internacionals” program with reference RDINT18-1-0004, and “Cupons a la Competitivitat Empresarial” program with reference ACE008/20/000441 and ACE008/20/000457.
GeoVista is a Non-Clinical Research Consultancy CRO that provides practical guidance for new drug development, by discussing the selection of appropriate CROs, studying procedures, and the results obtained via the developer.
The purpose of Spanish Drug Discovery Network (SDDN) is to create a forum where professionals working on the discovery and development of new drugs in Spain can get to know each other better, exchange ideas and discuss new initiatives and trends in the sector.
ASEBIO is the Spanish Bioindustry Association. ASEBIO brings together companies, associations, foundations, universities, and research and technology centers that carry out activities directly or indirectly related to biotechnology in Spain.
Biocat is the Catalan organization that coordinates and promotes the health and life sciences sector in the Catalonia region. Its mission is to maximize the economic and social impact of life science and healthcare innovation in the BioRegion.
The Biotechnology Markets Platform is the biotechnology platform that ASEBIO launched with the support of the Ministry of Economy and Competitiveness (MINECO) with the collaboration of the Spanish Society for Biotechnology (SEBIOT).
EuropaBio is the European Association for Bioindustries. Their mission is to create an innovative and dynamic biotechnology-based industry in Europe. They are actively engaged in raising awareness of the benefits of biotechnology in all sectors of society and in increasing knowledge and understanding of the industry.
of our industry.
CataloniaBio is the association of companies in the health and life sciences arena in Catalonia. Its mission is to represent and support companies interested in promoting a strategic, innovative research cluster, as well as helping them to define the framework for sector-wide actions and industrial policies established at a national and European level.
EIT Health was established in 2015, as a ‘knowledge and innovation community’ (KIC) of the European Institute of Innovation and Technology (EIT). Through this unique network of world-class healthcare organizations, EIT Health links entrepreneurial businesses with the knowledge and resources to scale up and scale out as quickly as possible. ‘EIT Health is supported by EIT, a body of the European Union’.